Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.57B |
| 2 |
Tesla
TSLA
|
+$1.06B |
| 3 |
Amazon
AMZN
|
+$597M |
| 4 |
Qualcomm
QCOM
|
+$374M |
| 5 |
AbbVie
ABBV
|
+$373M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$561M |
| 3 |
UnitedHealth
UNH
|
+$353M |
| 4 |
Meta Platforms (Facebook)
META
|
+$345M |
| 5 |
Starbucks
SBUX
|
+$340M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.9% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.48% |
| 5 | Industrials | 7.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
601
Southside Bancshares
SBSI
$984M
| $42.3M | 0.03% |
1,139,446
-69,364
| -6% | -$2.45M |
|
602
Carvana
CVNA
$81B
| $42.3M | 0.03% |
2,297,000
+146,000
| +7% | +$2.44M |
|
|
ACIA
603
DELISTED
Acacia Communications Inc
ACIA
| $42.2M | 0.03% |
622,700
-143,800
| -19% | -$9.53M |
|
604
Banco de Chile
BCH
$20.5B
| $42.1M | 0.03% |
2,006,975
-45,500
| -2% | -$1.11M |
|
605
REX American Resources
REX
$1.44B
| $42M | 0.03% |
3,075,258
+63,474
| +2% | +$878K |
|
606
Ovintiv
OVV
$17.2B
| $41.9M | 0.03% |
1,787,980
-1,764,840
| -50% | -$37.8M |
|
607
WPP
WPP
$5.82B
| $41.8M | 0.03% |
594,200
+3,100
| +0.5% | +$197K |
|
608
Albany International
AIN
$1.82B
| $41.5M | 0.03% |
546,300
-111,300
| -17% | -$9.25M |
|
|
TECD
609
DELISTED
Tech Data Corp
TECD
| $41.5M | 0.03% |
288,742
+164,300
| +132% | +$21.1M |
|
610
Boston Properties
BXP
$11B
| $41.5M | 0.03% |
300,700
+5,200
| +2% | +$700K |
|
611
Texas Capital Bancshares
TCBI
$4.38B
| $41.2M | 0.03% |
726,200
+286,700
| +65% | +$16.3M |
|
612
Emergent Biosolutions
EBS
$230M
| $41.2M | 0.03% |
764,101
-220,210
| -22% | -$11.9M |
|
613
PayPal
PYPL
$51.8B
| $41.2M | 0.03% |
380,871
-260,929
| -41% | -$27.2M |
|
|
GMS
614
DELISTED
GMS Inc
GMS
| $41.2M | 0.03% |
1,520,084
+212,184
| +16% | +$6.22M |
|
615
Herc Holdings
HRI
$5.64B
| $41.1M | 0.03% |
839,800
+162,800
| +24% | +$7.6M |
|
|
CTT
616
DELISTED
CATCHMARK TIMBER TRUST, INC.
CTT
| $41.1M | 0.03% |
3,582,372
+303,060
| +9% | +$3.45M |
|
|
BMCH
617
DELISTED
BMC Stock Holdings, Inc
BMCH
| $41M | 0.03% |
1,427,649
+122,549
| +9% | +$3.45M |
|
|
CERN
618
DELISTED
Cerner Corp
CERN
| $40.9M | 0.03% |
557,704
+404,600
| +264% | +$28M |
|
619
Tandem Diabetes Care
TNDM
$1.61B
| $40.8M | 0.03% |
684,900
-608,727
| -47% | -$37.5M |
|
|
WBK
620
DELISTED
Westpac Banking Corporation
WBK
| $40.8M | 0.03% |
2,402,373
+335,055
| +16% | +$6.06M |
|
|
NFBK
621
DELISTED
Northfield Bancorp
NFBK
| $40.8M | 0.03% |
2,405,137
+76,819
| +3% | +$1.29M |
|
622
Iridium Communications
IRDM
$5.27B
| $40.8M | 0.03% |
1,655,000
-353,100
| -18% | -$8.46M |
|
623
Waterstone Financial
WSBF
$385M
| $40.7M | 0.03% |
2,138,800
-11,500
| -0.5% | -$212K |
|
624
Urban Edge Properties
UE
$2.78B
| $40.6M | 0.03% |
2,115,900
+258,600
| +14% | +$5.23M |
|
|
NUAN
625
DELISTED
Nuance Communications, Inc.
NUAN
| $40.4M | 0.03% |
+2,263,455
| New | +$37.5M |
|
Similar funds
Jim Simons's Q4 2019 Portfolio in Review
As of Q4 2019, Jim Simons held 3,913 positions worth $130B, up 10% from $118B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jim Simons's Q4 2019 filing shows 518 new, 1,836 increased, 1,085 reduced and 443 closed positions. Its largest new stake was Amazon: 6,745,100 shares worth $623M. The largest sale was Celgene Corp, an estimated $1.54B.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2019 buy was Amazon: 6,745,100 shares worth $623M.
- Jim Simons added most to Bristol-Myers Squibb in Q4 2019, an estimated $1.57B increase.
- Jim Simons's biggest Q4 2019 reduction was Johnson & Johnson, cutting an estimated $561M.
- Jim Simons fully exited Celgene Corp in Q4 2019, selling an estimated $1.54B.
- Jim Simons's ten largest holdings make up 13% of its $130B portfolio in Q4 2019.
- Jim Simons opened 518 new positions and closed 443 in Q4 2019.
- Jim Simons's portfolio value rose 10% quarter-over-quarter to $130B.
Based on Renaissance Technologies's 13F filing for Q4 2019, filed 13 Feb 2020.